Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Consumption of Sugar-Sweetened Beverages, Juice, Artificially-Sweetened Soda and Bottled Water: An Australian Population Study.

Miller C, Ettridge K, Wakefield M, Pettigrew S, Coveney J, Roder D, Durkin S, Wittert G, Martin J, Dono J.

Nutrients. 2020 Mar 19;12(3). pii: E817. doi: 10.3390/nu12030817.

2.

Prospective Longitudinal Evaluation of Nascent Geographic Atrophy in Age-Related Macular Degeneration.

Wu Z, Luu CD, Hodgson LAB, Caruso E, Tindill N, Aung KZ, McGuinness MB, Makeyeva G, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Guymer RH.

Ophthalmol Retina. 2019 Dec 16. pii: S2468-6530(19)30675-X. doi: 10.1016/j.oret.2019.12.011. [Epub ahead of print]

PMID:
32088159
3.

Public support for introducing cigarette pack inserts in Australia.

Brennan E, Ilchenko E, Durkin SJ, Wakefield MA.

Tob Control. 2020 Feb 13. pii: tobaccocontrol-2019-055519. doi: 10.1136/tobaccocontrol-2019-055519. [Epub ahead of print] No abstract available.

PMID:
32054727
4.

Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.

Worthington J, Feletto E, Lew JB, Broun K, Durkin S, Wakefield M, Grogan P, Harper T, Canfell K.

Public Health. 2020 Feb;179:90-99. doi: 10.1016/j.puhe.2019.10.003. Epub 2019 Nov 22.

5.

Smoking prevalence following tobacco tax increases in Australia between 2001 and 2017: an interrupted time-series analysis.

Wilkinson AL, Scollo MM, Wakefield MA, Spittal MJ, Chaloupka FJ, Durkin SJ.

Lancet Public Health. 2019 Dec;4(12):e618-e627. doi: 10.1016/S2468-2667(19)30203-8. Epub 2019 Nov 20.

6.

Reply.

Guymer RH, Wu Z, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Luu CD; LEAD Study Group.

Ophthalmology. 2019 Dec;126(12):e92-e93. doi: 10.1016/j.ophtha.2019.07.017. No abstract available.

PMID:
31759505
7.

Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report.

Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH; LEAD Study Group.

Ophthalmol Retina. 2019 Dec;3(12):1026-1034. doi: 10.1016/j.oret.2019.07.008. Epub 2019 Jul 22.

PMID:
31582304
8.

Impact of a mass media campaign on participation in the Australian bowel cancer screening program.

Durkin S, Broun K, Guerin N, Morley B, Wakefield M.

J Med Screen. 2020 Mar;27(1):18-24. doi: 10.1177/0969141319874372. Epub 2019 Sep 17. No abstract available.

PMID:
31530160
9.

Increasing bowel cancer screening participation: integrating population-wide, primary care and more targeted approaches.

Lofti-Jam KL, O'Reilly CL, Feng CS, Wakefield MA, Durkin S, Broun KH.

Public Health Res Pract. 2019 Jul 31;29(2). pii: 2921916. doi: 10.17061/phrp2921916.

10.

Are Australians ready for warning labels, marketing bans and sugary drink taxes? Two cross-sectional surveys measuring support for policy responses to sugar-sweetened beverages.

Miller CL, Dono J, Wakefield MA, Pettigrew S, Coveney J, Roder D, Durkin SJ, Wittert G, Martin J, Ettridge KA.

BMJ Open. 2019 Jun 27;9(6):e027962. doi: 10.1136/bmjopen-2018-027962.

11.

Hardening or softening? An observational study of changes to the prevalence of hardening indicators in Victoria, Australia, 2001-2016.

Brennan E, Greenhalgh EM, Durkin SJ, Scollo MM, Hayes L, Wakefield MA.

Tob Control. 2019 May 30. pii: tobaccocontrol-2019-054937. doi: 10.1136/tobaccocontrol-2019-054937. [Epub ahead of print]

PMID:
31147477
12.

Impact of a mass media campaign on participation rates in a National Bowel Cancer Screening Program: a field experiment.

Durkin SJ, Broun K, Spittal MJ, Wakefield MA.

BMJ Open. 2019 Jan 25;9(1):e024267. doi: 10.1136/bmjopen-2018-024267.

13.

Anti-smoking social norms are associated with increased cessation behaviours among lower and higher socioeconomic status smokers: A population-based cohort study.

Schoenaker DAJM, Brennan E, Wakefield MA, Durkin SJ.

PLoS One. 2018 Dec 12;13(12):e0208950. doi: 10.1371/journal.pone.0208950. eCollection 2018.

14.

Indexation of Tobacco Excise and Customs Duty and Smoking Prevalence Among Australian Adults, 2001-2010: A Serial Cross-sectional Study.

Wilkinson AL, Scollo M, Durkin SJ, Bayly M, Spittal MJ, Chaloupka FJ, Wakefield MA.

Nicotine Tob Res. 2019 Feb 18;21(3):293-299. doi: 10.1093/ntr/nty213.

PMID:
30304468
15.

Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial.

Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD; Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group.

Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20.

16.

Fear, Sadness and Hope: Which Emotions Maximize Impact of Anti-Tobacco Mass Media Advertisements among Lower and Higher SES Groups?

Durkin S, Bayly M, Brennan E, Biener L, Wakefield M.

J Health Commun. 2018;23(5):445-461. doi: 10.1080/10810730.2018.1463320. Epub 2018 Apr 27.

PMID:
29702038
17.

Influence of premium vs masked cigarette brand names on the experienced taste of a cigarette after tobacco plain packaging in Australia: an experimental study.

Skaczkowski G, Durkin S, Kashima Y, Wakefield M.

BMC Public Health. 2018 Mar 12;18(1):295. doi: 10.1186/s12889-018-5200-8.

18.

Immediate effects on adult drinkers of exposure to alcohol harm reduction advertisements with and without drinking guideline messages: experimental study.

Wakefield MA, Brennan E, Dunstone K, Durkin SJ, Dixon HG, Pettigrew S, Slater MD.

Addiction. 2018 Jun;113(6):1019-1029. doi: 10.1111/add.14147. Epub 2018 Feb 27.

PMID:
29486097
19.

Adolescents' alcohol use and strength of policy relating to youth access, trading hours and driving under the influence: findings from Australia.

White V, Azar D, Faulkner A, Coomber K, Durkin S, Livingston M, Chikritzhs T, Room R, Wakefield M.

Addiction. 2018 Jun;113(6):1030-1042. doi: 10.1111/add.14164. Epub 2018 Feb 21.

PMID:
29356174
20.

Competing with big business: a randomised experiment testing the effects of messages to promote alcohol and sugary drink control policy.

Scully M, Brennan E, Durkin S, Dixon H, Wakefield M, Barry CL, Niederdeppe J.

BMC Public Health. 2017 Dec 28;17(1):945. doi: 10.1186/s12889-017-4972-6.

21.

Atypical case of hyaluronidase allergy with orbital compartment syndrome and visual loss.

Halliday L, Sia PI, Durkin S, Selva D.

Clin Exp Ophthalmol. 2018 Jul;46(5):563-564. doi: 10.1111/ceo.13128. Epub 2017 Dec 28. No abstract available.

PMID:
29219234
22.

Public awareness and misunderstanding about DrinkWise Australia: a cross-sectional survey of Australian adults.

Brennan E, Wakefield MA, Durkin SJ, Jernigan DH, Dixon HG, Pettigrew S.

Aust N Z J Public Health. 2017 Aug;41(4):352-357. doi: 10.1111/1753-6405.12674. Epub 2017 Jun 29.

PMID:
28664575
23.

Adolescents' exposure to paid alcohol advertising on television and their alcohol use: exploring associations during a 13-year period.

White V, Azar D, Faulkner A, Coomber K, Durkin S, Livingston M, Chikritzhs T, Room R, Wakefield M.

Addiction. 2017 Oct;112(10):1742-1751. doi: 10.1111/add.13873. Epub 2017 Jul 6.

PMID:
28544093
24.

Features of alcohol harm reduction advertisements that most motivate reduced drinking among adults: an advertisement response study.

Wakefield MA, Brennan E, Dunstone K, Durkin SJ, Dixon HG, Pettigrew S, Slater MD.

BMJ Open. 2017 Apr 20;7(4):e014193. doi: 10.1136/bmjopen-2016-014193.

25.

Alcohol harm reduction advertisements: a content analysis of topic, objective, emotional tone, execution and target audience.

Dunstone K, Brennan E, Slater MD, Dixon HG, Durkin SJ, Pettigrew S, Wakefield MA.

BMC Public Health. 2017 Apr 11;17(1):312. doi: 10.1186/s12889-017-4218-7.

26.

BSS Plus compared to the vitreous of non-diabetics and diabetics.

Kokavec J, Horo S, Chan WO, Min SH, Tan MH, Grigg J, Gilhotra JS, Newland HS, Durkin SR, Casson RJ.

Clin Exp Ophthalmol. 2017 Aug;45(6):656-657. doi: 10.1111/ceo.12923. Epub 2017 Mar 21. No abstract available.

PMID:
28170153
27.

Influence of premium versus value brand names on the smoking experience in a plain packaging environment: an experimental study.

Skaczkowski G, Durkin S, Kashima Y, Wakefield M.

BMJ Open. 2017 Jan 16;7(1):e014099. doi: 10.1136/bmjopen-2016-014099.

28.

Subthreshold Nanosecond Laser Intervention in Intermediate Age-Related Macular Degeneration: Study Design and Baseline Characteristics of the Laser in Early Stages of Age-Related Macular Degeneration Study (Report Number 1).

Lek JJ, Brassington KH, Luu CD, Chen FK, Arnold JJ, Heriot WJ, Durkin SR, Chakravarthy U, Guymer RH; Laser in Early Stages of Age-Related Macular Degeneration Study Writing Committee.

Ophthalmol Retina. 2017 May - Jun;1(3):227-239. doi: 10.1016/j.oret.2016.12.001. Epub 2017 Jan 31.

PMID:
31047426
29.

Why Do Smokers Talk About Antismoking Campaigns? Predictors of the Occurrence and Content of Campaign-Generated Conversations.

Brennan E, Durkin SJ, Wakefield M, Kashima Y.

Health Commun. 2017 Dec;32(12):1539-1556. doi: 10.1080/10410236.2016.1239301. Epub 2016 Nov 30.

PMID:
27902887
30.

Manganese in the human vitreous.

Kokavec J, Min SH, Tan MH, Gilhotra JS, Newland HS, Durkin SR, Casson RJ.

Clin Exp Ophthalmol. 2016 Sep;44(7):646. doi: 10.1111/ceo.12736. Epub 2016 Apr 6. No abstract available.

PMID:
26936085
31.

Biochemical analysis of the living human vitreous.

Kokavec J, Min SH, Tan MH, Gilhotra JS, Newland HS, Durkin SR, Grigg J, Casson RJ.

Clin Exp Ophthalmol. 2016 Sep;44(7):597-609. doi: 10.1111/ceo.12732. Epub 2016 Apr 19.

PMID:
26891415
32.

Aqueous Chlorhexidine for Intravitreal Injection Antisepsis: A Case Series and Review of the Literature.

Merani R, McPherson ZE, Luckie AP, Gilhotra JS, Runciman J, Durkin S, Muecke J, Donaldson M, Aralar A, Rao A, Davies PE.

Ophthalmology. 2016 Dec;123(12):2588-2594. doi: 10.1016/j.ophtha.2016.08.022. Epub 2016 Oct 6. Review.

PMID:
27720552
33.

Antemortem vitreous potassium may strengthen postmortem interval estimates.

Kokavec J, Min SH, Tan MH, Gilhotra JS, Newland HS, Durkin SR, Casson RJ.

Forensic Sci Int. 2016 Jun;263:e18. doi: 10.1016/j.forsciint.2016.03.027. Epub 2016 Mar 19.

PMID:
27080618
34.

The effect of packaging, branding and labeling on the experience of unhealthy food and drink: A review.

Skaczkowski G, Durkin S, Kashima Y, Wakefield M.

Appetite. 2016 Apr 1;99:219-234. doi: 10.1016/j.appet.2016.01.022. Epub 2016 Jan 16. Review.

PMID:
26785316
35.

Plain packaging implementation: perceptions of risk and prestige of cigarette brands among Aboriginal and Torres Strait Islander people.

Maddox R, Durkin S, Lovett R.

Aust N Z J Public Health. 2016 Jun;40(3):221-5. doi: 10.1111/1753-6405.12489. Epub 2015 Dec 29.

PMID:
26713418
36.

Intravitreal Triamcinolone Deposition Mimicking Frosted Branch Angiitis: Optical Coherence Tomography Findings.

Sia DI, Durkin S.

Retina. 2016 Jun;36(6):e41-2. doi: 10.1097/IAE.0000000000000928. No abstract available.

PMID:
26655615
37.

Universal Health Care Identifiers: The Challenge of Linking Medical Records.

Davidson S, Durkin S, Subburamu S.

J Ambul Care Manage. 2016 Jan-Mar;39(1):53-62.

PMID:
26650746
38.

Which Type of Antismoking Advertisement Is Perceived as More Effective? An Experimental Study With a Sample of Australian Socially Disadvantaged Welfare Recipients.

Guillaumier A, Bonevski B, Paul C, d'Este C, Durkin S, Doran C.

Am J Health Promot. 2017 May;31(3):209-216. doi: 10.4278/ajhp.141125-QUAN-593. Epub 2015 Nov 11.

PMID:
26559713
39.

Talking About Antismoking Campaigns: What Do Smokers Talk About, and How Does Talk Influence Campaign Effectiveness?

Brennan E, Durkin SJ, Wakefield MA, Kashima Y.

J Health Commun. 2016;21(1):33-45. doi: 10.1080/10810730.2015.1039675. Epub 2015 Sep 16.

PMID:
26376358
40.

Finding the keys to successful adult-targeted advertisements on obesity prevention: an experimental audience testing study.

Dixon H, Scully M, Durkin S, Brennan E, Cotter T, Maloney S, O'Hara BJ, Wakefield M.

BMC Public Health. 2015 Aug 20;15:804. doi: 10.1186/s12889-015-2159-6.

41.

Personal pack display and active smoking at outdoor café strips: assessing the impact of plain packaging 1 year postimplementation.

Zacher M, Bayly M, Brennan E, Dono J, Miller C, Durkin S, Scollo M, Wakefield M.

Tob Control. 2015 Apr;24(Suppl 2):ii94-ii97. doi: 10.1136/tobaccocontrol-2014-051826. Epub 2015 Feb 25.

42.

Are quitting-related cognitions and behaviours predicted by proximal responses to plain packaging with larger health warnings? Findings from a national cohort study with Australian adult smokers.

Brennan E, Durkin S, Coomber K, Zacher M, Scollo M, Wakefield M.

Tob Control. 2015 Apr;24(Suppl 2):ii33-ii41. doi: 10.1136/tobaccocontrol-2014-052057. Epub 2015 Feb 25.

43.

Short-term changes in quitting-related cognitions and behaviours after the implementation of plain packaging with larger health warnings: findings from a national cohort study with Australian adult smokers.

Durkin S, Brennan E, Coomber K, Zacher M, Scollo M, Wakefield M.

Tob Control. 2015 Apr;24(Suppl 2):ii26-ii32. doi: 10.1136/tobaccocontrol-2014-052058. Epub 2015 Feb 25.

44.

Australian adult smokers' responses to plain packaging with larger graphic health warnings 1 year after implementation: results from a national cross-sectional tracking survey.

Wakefield M, Coomber K, Zacher M, Durkin S, Brennan E, Scollo M.

Tob Control. 2015 Apr;24(Suppl 2):ii17-ii25. doi: 10.1136/tobaccocontrol-2014-052050. Epub 2015 Feb 25.

45.

Change in vision after retinal pigment epithelium tear following the use of anti-VEGF therapy for age-related macular degeneration.

Durkin SR, Farmer LD, Kulasekara S, Gilhotra J.

Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):1-6. doi: 10.1007/s00417-015-2978-2. Epub 2015 Mar 8.

PMID:
25749721
47.

Sodalis glossinidius prevalence and trypanosome presence in tsetse from Luambe National Park, Zambia.

Dennis JW, Durkin SM, Horsley Downie JE, Hamill LC, Anderson NE, MacLeod ET.

Parasit Vectors. 2014 Aug 19;7:378. doi: 10.1186/1756-3305-7-378.

48.

Time series analysis of the impact of tobacco control policies on smoking prevalence among Australian adults, 2001-2011.

Wakefield MA, Coomber K, Durkin SJ, Scollo M, Bayly M, Spittal MJ, Simpson JA, Hill D.

Bull World Health Organ. 2014 Jun 1;92(6):413-22. doi: 10.2471/BLT.13.118448. Epub 2014 Mar 18.

49.

Managing the integrity of patient identity in health information exchange (updated).

Dooling JA, Durkin S, Fernandes L, Just B, Kotyk S, Karl ES, Westhafer K.

J AHIMA. 2014 May;85(5):60-5. No abstract available.

PMID:
24938040
50.

Standardized metadata for human pathogen/vector genomic sequences.

Dugan VG, Emrich SJ, Giraldo-Calderón GI, Harb OS, Newman RM, Pickett BE, Schriml LM, Stockwell TB, Stoeckert CJ Jr, Sullivan DE, Singh I, Ward DV, Yao A, Zheng J, Barrett T, Birren B, Brinkac L, Bruno VM, Caler E, Chapman S, Collins FH, Cuomo CA, Di Francesco V, Durkin S, Eppinger M, Feldgarden M, Fraser C, Fricke WF, Giovanni M, Henn MR, Hine E, Hotopp JD, Karsch-Mizrachi I, Kissinger JC, Lee EM, Mathur P, Mongodin EF, Murphy CI, Myers G, Neafsey DE, Nelson KE, Nierman WC, Puzak J, Rasko D, Roos DS, Sadzewicz L, Silva JC, Sobral B, Squires RB, Stevens RL, Tallon L, Tettelin H, Wentworth D, White O, Will R, Wortman J, Zhang Y, Scheuermann RH.

PLoS One. 2014 Jun 17;9(6):e99979. doi: 10.1371/journal.pone.0099979. eCollection 2014.

Supplemental Content

Loading ...
Support Center